摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

反式-2-(4-联苯)乙烯基硼酸 | 352530-23-5

中文名称
反式-2-(4-联苯)乙烯基硼酸
中文别名
反式-2-(4-联苯基)乙烯基硼酸
英文名称
(E)-4-phenylstyrylboronic acid
英文别名
(E)-(2-([1,1'-biphenyl]-4-yl)vinyl)boronic acid;trans-2-(4-biphenyl)vinylboronic acid;(E)-(2-([1,1’-biphenyl]-4-yl)vinyl)boronic acid;trans-2-(4-phenylphenyl)vinylboronic acid;[(E)-2-(4-phenylphenyl)ethenyl]boronic acid
反式-2-(4-联苯)乙烯基硼酸化学式
CAS
352530-23-5
化学式
C14H13BO2
mdl
——
分子量
224.067
InChiKey
NTRGFVQIGQYKIL-ZHACJKMWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    134-139 °C (lit.)
  • 沸点:
    439.3±48.0 °C(Predicted)
  • 密度:
    1.142±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.38
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 储存条件:
    2-8°C,惰性气体

SDS

SDS:bcf3d53e3f11794d8f9fb484bc9556ca
查看

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : trans-2-(4-Biphenyl)vinylboronic acid
CAS-No. : 352530-23-5
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances



Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
Caution - substance not yet tested completely.
Other hazards - none

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C14H13BO2
Molecular Weight : 224,06 g/mol

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Indication of any immediate medical attention and special treatment needed
no data available

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Borane/boron oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 134 - 139 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Additional Information
RTECS: Not available

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    反式-2-(4-联苯)乙烯基硼酸三氟甲磺酸1,8-二氮杂双环[5.4.0]十一碳-7-烯间氯过氧苯甲酸 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 2.41h, 生成 (1-([1,1'-biphenyl]-4-yl)vinyl)diphenylphosphine oxide
    参考文献:
    名称:
    Transition metal-free and regioselective vinylation of phosphine oxides and H-phosphinates with VBX reagents
    摘要:
    Vinylbenziodoxolones(VBX)被证明是高效的、无金属的P-烯基化试剂,具有完全偏向末端烯烃的区域选择性。
    DOI:
    10.1039/d0cc05992g
  • 作为产物:
    描述:
    4-乙炔联苯 作用下, 以 四氢呋喃 为溶剂, 生成 反式-2-(4-联苯)乙烯基硼酸
    参考文献:
    名称:
    Anomalies in the Stereoselectivity of the Petasis Reaction Using Styrenyl Boronic Acids
    摘要:
    Petasis 的 N-苄基苯基甘氨醇、乙醛酸和苯乙烯硼酸三组分偶联反应可以高效合成官能化均芳基丙氨酸衍生物。研究表明,无论苯乙烯硼酸组分上的取代基性质如何,反应的产率都很高,但选择性较低。与以前报告的结果相比,这些反应在立体选择性方面的异常现象可追溯到有机硼酸的来源。不饱和氨基酸衍生物的不对称二羟基化是获得二羟基高芳基丙氨酸衍生物的高效途径。
    DOI:
    10.1071/ch10341
点击查看最新优质反应信息

文献信息

  • Rate Dependence on Inductive and Resonance Effects for the Organocatalyzed Enantioselective Conjugate Addition of Alkenyl and Alkynyl Boronic Acids to β-Indolyl Enones and β-Pyrrolyl Enones
    作者:Amy Boylan、Thien S. Nguyen、Brian J. Lundy、Jian-Yuan Li、Ravikrishna Vallakati、Sasha Sundstrom、Jeremy A. May
    DOI:10.3390/molecules26061615
    日期:——
    Two key factors bear on reaction rates for the conjugate addition of alkenyl boronic acids to heteroaryl-appended enones: the proximity of inductively electron-withdrawing heteroatoms to the site of bond formation and the resonance contribution of available heteroatom lone pairs to stabilize the developing positive charge at the enone β-position. For the former, the closer the heteroatom is to the
    影响烯基硼酸与杂芳基连接的烯酮共轭加成反应速率的两个关键因素:感应吸电子杂原子与成键位点的接近度以及可用杂原子孤对对稳定产生的正电荷的共振贡献在烯酮β-位。对于前者,杂原子距离烯酮β-碳越近,反应越快。对于后者,苄基阳离子电荷的共振稳定性更强,可加速反应。因此,反应速率通过感应吸电子元件的更接近而增加,但如果涉及共振效应,则观察到具有给电子能力的速率增加。提出了异构底物这些趋势的证据,并且这些见解的应用允许反应条件改善与以前有问题的底物的反应性。
  • Modular Synthesis of <i>trans</i> ‐A <sub>2</sub> B <sub>2</sub> ‐Porphyrins with Terminal Esters: Systematically Extending the Scope of Linear Linkers for Porphyrin‐Based MOFs
    作者:Stefan M. Marschner、Ritesh Haldar、Olaf Fuhr、Christof Wöll、Stefan Bräse
    DOI:10.1002/chem.202003885
    日期:2021.1.18
    two decades. Herein we report the synthesis of a large range of 5,15‐bis(4‐ethoxycarbonylphenyl)porphyrin derivatives, through Suzuki and Sonogashira cross‐coupling reactions of an easily accessible corresponding meso‐dibrominated trans‐A2B2‐porphyrin with commercially available boronic acids or terminal alkynes. The resulting porphyrins were fully characterized through NMR, MS, and IR spectroscopy and
    不同功能化的卟啉连接体代表了合成新型卟啉基金属有机框架(MOF)的关键化合物,在过去的二十年中引起了人们的极大兴趣。在此,我们报道了通过易于获得的相应内消旋二溴化反式-A 2 B 2卟啉与市售产品的 Suzuki 和 Sonogashira 交叉偶联反应,合成了多种 5,15-双(4-乙氧基羰基苯基)卟啉衍生物。硼酸或末端炔烃。通过核磁共振、质谱和红外光谱对所得卟啉进行了全面表征,并通过紫外/可见光吸收进行了系统研究。最后,将选定的结构皂化为相应的羧酸,随后证明适合合成表面锚定的 MOF 薄膜。
  • CARBON LINKED MODULATORS OF gamma-SECRETASE
    申请人:HO Chih Yung
    公开号:US20090105288A1
    公开(公告)日:2009-04-23
    The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.
    本发明涉及如下所示的公式I的化合物,其中规定了A、X、R1、R3、R4、R5、R6、R7、R8和R9的定义。公式I的化合物可用于治疗与γ-分泌酶活性相关的疾病,包括阿尔茨海默病。
  • A multicomponent approach for the preparation of homoallylic alcohols
    作者:Jian-Siang Poh、Shing-Hing Lau、Iain G. Dykes、Duc N. Tran、Claudio Battilocchio、Steven V. Ley
    DOI:10.1039/c6sc02581a
    日期:——
    Here we report the in situ generation of transient allylic boronic species, by reacting TMSCHN2 and E-vinyl boronic acids, followed by their subsequent trapping with aldehydes as electrophiles to yield...
    在这里,我们报告了通过使TMSCHN2和E-乙烯基硼酸反应,然后将其随后与醛作为亲电试剂进行捕获,从而产生瞬时烯丙基硼酸物种的原位生成方法...
  • [EN] GSM INTERMEDIATES<br/>[FR] INTERMÉDIAIRES GSM
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2009052341A1
    公开(公告)日:2009-04-23
    The present invention relates the use of compounds having the general Formula I, wherein the definitions or R1 and R2 are provided in the specification. Said compounds of Formula I are useful for the synthesis of a variety of g-secretase modulators, which are in turn useful for the treatment of diseases associated with y-secretase activity, including Alzheimer´s disease.
    本发明涉及具有通用公式I的化合物的使用,其中R1和R2的定义在说明书中提供。所述公式I的化合物可用于合成多种γ-分泌酶调节剂,这些调节剂又可用于治疗与γ-分泌酶活性相关的疾病,包括阿尔茨海默病。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐